TOBACCO behemoth Philip Morris International has launched an array of marketing collateral around its VEEV nicotine vaping products targeting health professionals.
As well as heavily discounted offers to pharmacy (PD breaking news), GPs are also being targeted with information about prescribing the items as smoking cessation aids.
Direct-to-pharmacy Philip Morris offers promise high margins, with devices retailing at $19.90 and pod two-packs for $14.90.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
